Ia expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured T cell lines in mice
- PMID: 2419666
Ia expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured T cell lines in mice
Abstract
Chronic relapsing experimental allergic encephalomyelitis was induced in SJL mice by adoptive transfer of long-term cultured T cell lines. The T cells which were activated with myelin basic protein (MBP) derived from various species, all induced chronic relapsing experimental allergic encephalomyelitis with a similar high incidence. During the relapsing stage, lymphocytes obtained from the spleen responded well to MBP and were capable of transferring experimental allergic encephalomyelitis, whereas thymus lymphocytes did not respond to MBP. There was no difference in the proliferative response of splenocytes to MBP when splenocytes were isolated either from mice with clinical relapse or from mice that did not relapse. Pathological examination revealed a transient appearance of inflammatory cells during the acute stage. Similar cell infiltrates were also observed at the relapsing stage. The I-region associated (Ia) antigens appeared on vessels and astrocytes in the acute inflammatory lesions which coincided with the appearance of inflammatory cell infiltrates. Ia antigen expression diminished with the disappearance of inflammatory cells. During the relapsing stage, the Ia antigens were also expressed on the vessels and astrocytes in the fresh lesions. Our data indicate that MBP-reactive T cells persist at least in the spleen, for a long time. They may be reactivated by certain mechanisms probably in the central nervous system associated with the Ia-antigen expression, which facilitates the effector phase again. The initial event that triggers the Ia-expression is not known as yet.
Similar articles
-
Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis.Lab Invest. 1990 Aug;63(2):162-70. Lab Invest. 1990. PMID: 1696331
-
Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis.J Immunol. 1987 Mar 1;138(5):1434-41. J Immunol. 1987. PMID: 2433347
-
Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.Lab Invest. 1994 Nov;71(5):671-9. Lab Invest. 1994. PMID: 7526038
-
Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells.J Exp Biol. 1987 Sep;132:43-57. doi: 10.1242/jeb.132.1.43. J Exp Biol. 1987. PMID: 3323405 Review.
-
The case against epitope spread in experimental allergic encephalomyelitis.Immunol Rev. 1998 Aug;164:101-10. doi: 10.1111/j.1600-065x.1998.tb01212.x. Immunol Rev. 1998. PMID: 9795768 Review.
Cited by
-
The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis.J Neuroinflammation. 2013 May 24;10:67. doi: 10.1186/1742-2094-10-67. J Neuroinflammation. 2013. PMID: 23705890 Free PMC article.
-
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.Am J Pathol. 1988 Mar;130(3):443-54. Am J Pathol. 1988. PMID: 2450462 Free PMC article.
-
Pathogenesis of virus-induced demyelination.Adv Virus Res. 1993;42:249-324. doi: 10.1016/s0065-3527(08)60087-1. Adv Virus Res. 1993. PMID: 8430521 Free PMC article. Review.
-
In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.J Exp Med. 1987 Sep 1;166(3):798-803. doi: 10.1084/jem.166.3.798. J Exp Med. 1987. PMID: 3114409 Free PMC article.
-
Astrocytes and intracerebral immune responses.J Clin Immunol. 1989 Jan;9(1):1-9. doi: 10.1007/BF00917121. J Clin Immunol. 1989. PMID: 2649507 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous